MOESM2 of Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus

Additional file 2: Figure S1. Kaplan–Meier curves of freedom from all-cause mortality (A, B) and composite endpoints (C, D) for low and high HbA1c variability after 42-month follow-up in HFpEF. The numbers at the bottom of the figure are “number at risk”.